Michael Arand
Impact in
- Biochemistry top 0.2%
- Eicosanoids and Hypertension Pharmacology
- Immunology top 0.5%
- Immunotherapy and Immune Responses
Papers in
- Pharmacology 45
- Pharmacogenetics and Drug Metabolism 42
- Drug-Induced Hepatotoxicity and Protection 6
- Biochemistry 31
- Eicosanoids and Hypertension Pharmacology 30
- Co-authors
- Franz Oesch (63 shared papers)Julia Karbach (16 shared papers)Alexander K. Knuth (15 shared papers)Elke Jäger (13 shared papers)Lloyd J. Old (9 shared papers)Elisabeth Stockert (8 shared papers)Yao‐Tseng Chen (8 shared papers)Mark Ringhoffer (8 shared papers)
- Journals
- Archives of Toxicology (11 papers)Biochemical Journal (9 papers)International Journal of Cancer (6 papers)Proceedings of the National Academy of Sciences (5 papers)FEBS Letters (4 papers)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Michael Arand
121 papers receiving 8.3k citations
Peers
Comparison fields: 5 of 136
- Biochemistry 909
- Immunology 2.7k
- Pharmacology 839
- Biotechnology 254
- Oncology 799
Countries citing papers authored by Michael Arand
This map shows the geographic impact of Michael Arand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Arand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Arand more than expected).
Fields of papers citing papers by Michael Arand
This network shows the impact of papers produced by Michael Arand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Arand. The network helps show where Michael Arand may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Arand, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 121 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 626 | |
| 2 | 1998 | 625 | |
| 3 | 2000 | 374 | |
| 4 | 2000 | 351 | |
| 5 | 1996 | 301 | |
| 6 | 1996 | 266 | |
| 7 | 1997 | 260 | |
| 8 | 1996 | 235 | |
| 9 | 1998 | 210 | |
| 10 | 1996 | 206 | |
| 11 | 1999 | 201 | |
| 12 | 2000 | 193 | |
| 13 | 2009 | 179 | |
| 14 | 2000 | 153 | |
| 15 | 2005 | 151 | |
| 16 | 1994 | 137 | |
| 17 | 2009 | 136 | |
| 18 | 2015 | 133 | |
| 19 | 2020 | 132 | |
| 20 | 2003 | 131 |
About Michael Arand
Michael Arand is a scholar working on Pharmacology, Biochemistry, Immunology, Cancer Research and Molecular Biology, having authored 121 papers that have together received 8.6k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (42 papers), Eicosanoids and Hypertension Pharmacology (30 papers), Immunotherapy and Immune Responses (15 papers), Enzyme Catalysis and Immobilization (11 papers), Carcinogens and Genotoxicity Assessment (7 papers), Drug-Induced Hepatotoxicity and Protection (6 papers), Metal-Catalyzed Oxygenation Mechanisms (6 papers) and Enzyme Structure and Function (6 papers). The work is most often cited by research in Biochemistry (909 citations), Immunology (2.7k citations), Pharmacology (839 citations), Biotechnology (254 citations) and Oncology (799 citations). Michael Arand has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Franz Oesch, Julia Karbach, Alexander K. Knuth, Elke Jäger, Lloyd J. Old, Elisabeth Stockert, Yao‐Tseng Chen, Mark Ringhoffer, Annette Cronin and Jan Georg Hengstler. Their work appears in journals such as Archives of Toxicology, Biochemical Journal, International Journal of Cancer, Proceedings of the National Academy of Sciences and FEBS Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.